A Diet Low in Red and Processed Meat Does Not Reduce Rate of Crohn's Disease Flares
- PMID: 30872105
- PMCID: PMC6726378
- DOI: 10.1053/j.gastro.2019.03.015
A Diet Low in Red and Processed Meat Does Not Reduce Rate of Crohn's Disease Flares
Abstract
Background & aims: Diet may be an important factor in the progression of Crohn's disease (CD). We performed a randomized controlled trial to determine whether reduced consumption of red and processed meats decreases the risk of symptomatic relapse of CD, analyzing results from the Food and Crohn's Disease Exacerbation Study (FACES) trial.
Methods: Adults with CD were recruited into the FACES trial from IBD Partners, an Internet-based cohort of patients with inflammatory bowel disease, from November 2013 through June 2015. Individuals who were in remission (CD activity index [sCDAI] scores of ≤150), had completed a biannual survey, and reported consumption of red meat at least once weekly were randomly assigned to groups that consumed a minimum of 2 servings/week of red or processed meat (high meat, n = 118) or not more than 1 serving per month (low meat, n = 96) for 49 weeks. The primary outcome was relapse of CD, defined as increase in sCDAI score by ≥70 points and to >150 or a need for CD surgery or new CD medication. A secondary outcome, moderate or severe relapse, was based on an increase in sCDAI to >219.
Results: During the trial, the high-meat groups reported consumption of 2 or more servings of red or processed meat during 98.5% of observed weeks compared with 18.8% of weeks for the low-meat group. Any and moderate to severe relapse occurred in 62% of participants in the high-meat group and 42% of participants in the low-meat group. There were no significant differences in time to any (P = .61) or moderate/severe (P = .50) relapse.
Conclusions: In an analysis of data from the FACES trial, we found that among patients with CD in remission, level of red and processed meat consumption was not associated with time to symptomatic relapse. ClinicalTrials.gov, Number: NCT0192673.
Trial registration: ClinicalTrials.gov NCT00192673.
Keywords: IBD; Inflammatory Bowel Disease; Prevention; Quiescent Disease.
Copyright © 2019 AGA Institute. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Potential Conflicts of Interest:
Dr. Albenberg has received research funding from Seres Therapeutics.
Dr. Lewis has served as a consultant for: Nestle Health Science, Johnson & Johnson Consumer Inc, Janssen Pharmaceuticals, Takeda, AbbVie, Merck, Celgene, Eli Lilly and Company, Samsung Bioepis, Pfizer, Gilead, UCB, Arena Pharmaceuticals and Bridge Biotherapeutics. He has received research funding from Nestle Health Science, Takeda, and Janssen.
Dr. Kappelman has received research funding from and serves as a consultant for Johnson & Johnson Consumer Inc, Abbvie, Pfizer, and Eli Lilly. He is a shareholder to Johnson & Johnson Consumer Inc.
Figures




Similar articles
-
Saccharomyces boulardii does not prevent relapse of Crohn's disease.Clin Gastroenterol Hepatol. 2013 Aug;11(8):982-7. doi: 10.1016/j.cgh.2013.02.021. Epub 2013 Mar 1. Clin Gastroenterol Hepatol. 2013. PMID: 23466709 Clinical Trial.
-
Comparing Two Diets to Decrease Symptoms from Crohn's Disease – The DINE-CD Study [Internet].Washington (DC): Patient-Centered Outcomes Research Institute (PCORI); 2021 Oct. Washington (DC): Patient-Centered Outcomes Research Institute (PCORI); 2021 Oct. PMID: 39312597 Free Books & Documents. Review.
-
Lifestyle-related disease in Crohn's disease: relapse prevention by a semi-vegetarian diet.World J Gastroenterol. 2010 May 28;16(20):2484-95. doi: 10.3748/wjg.v16.i20.2484. World J Gastroenterol. 2010. PMID: 20503448 Free PMC article. Clinical Trial.
-
Association of ultra-processed food intake with risk of inflammatory bowel disease: prospective cohort study.BMJ. 2021 Jul 14;374:n1554. doi: 10.1136/bmj.n1554. BMJ. 2021. PMID: 34261638 Free PMC article.
-
Antibiotics for induction and maintenance of remission in Crohn's disease.Cochrane Database Syst Rev. 2019 Feb 7;2(2):CD012730. doi: 10.1002/14651858.CD012730.pub2. Cochrane Database Syst Rev. 2019. PMID: 30731030 Free PMC article.
Cited by
-
Are Nutrition Interventions to Augment Treatment Plans the Most Personalized Approach to Inflammatory Bowel Disease Therapy?Crohns Colitis 360. 2020 May 26;2(3):otaa043. doi: 10.1093/crocol/otaa043. eCollection 2020 Jul. Crohns Colitis 360. 2020. PMID: 36776502 Free PMC article. No abstract available.
-
Let Food Be Thy Medicine-Its Role in Crohn's Disease.Nutrients. 2021 Mar 3;13(3):832. doi: 10.3390/nu13030832. Nutrients. 2021. PMID: 33802429 Free PMC article. Review.
-
Therapy Strategies for Children Suffering from Inflammatory Bowel Disease (IBD)-A Narrative Review.Children (Basel). 2022 Apr 26;9(5):617. doi: 10.3390/children9050617. Children (Basel). 2022. PMID: 35626795 Free PMC article. Review.
-
Western and Carnivorous Dietary Patterns are Associated with Greater Likelihood of IBD Development in a Large Prospective Population-based Cohort.J Crohns Colitis. 2022 Jul 14;16(6):931-939. doi: 10.1093/ecco-jcc/jjab219. J Crohns Colitis. 2022. PMID: 34864946 Free PMC article.
-
Tumorigenesis in Inflammatory Bowel Disease: Microbiota-Environment Interconnections.Cancers (Basel). 2023 Jun 15;15(12):3200. doi: 10.3390/cancers15123200. Cancers (Basel). 2023. PMID: 37370812 Free PMC article. Review.
References
-
- Lochs H, Dejong C, Hammarqvist F, Hebuterne X, Leon-Sanz M, Schutz T, van Gemert W, van Gossum A, Valentini L, Lubke H, Bischoff S, Engelmann N, Thul P. 2006. ESPEN Guidelines on Enteral Nutrition: Gastroenterology. Clin Nutr 25:260–74. - PubMed
-
- Riordan AM, Hunter JO, Cowan RE, Crampton JR, Davidson AR, Dickinson RJ, Dronfield MW, Fellows IW, Hishon S, Kerrigan GN, et al. 1993. Treatment of active Crohn’s disease by exclusion diet: East Anglian multicentre controlled trial. Lancet 342:1131–4. - PubMed
-
- Bartel G, Weiss I, Turetschek K, Schima W, Puspok A, Waldhoer T, Gasche C. 2008. Ingested matter affects intestinal lesions in Crohn’s disease. Inflamm Bowel Dis 14:374–82. - PubMed
Publication types
MeSH terms
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Medical